Investigating treatment outcomes for patients with critical limb ischemia and end-stage renal disease
Official title: Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
Funded at University of Florida · NIH-10897869 · Data updated 2026-11-12
This study is looking at the best treatment options for people with critical limb ischemia who also have severe kidney disease, to help doctors and patients make better choices about care and improve health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | August 1, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $146,956 |
| NIH project number | 5K23HL161428-03 |
| Project ID | NIH-10897869 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with both critical limb ischemia and end-stage renal disease.
✕Less likely to help
Patients who do not have critical limb ischemia or end-stage renal disease may not benefit from this research.
What this research studies
This research focuses on understanding the treatment options and outcomes for patients suffering from critical limb ischemia (CLI) who also have end-stage renal disease (ESRD). It examines various treatment methods, including catheter-based procedures, surgery, and symptom management, to determine their effectiveness and impact on patient mortality and amputation rates. The study aims to gather real-world evidence to guide treatment decisions and improve shared decision-making between patients and healthcare providers. By analyzing patient outcomes and factors influencing treatment choices, the research seeks to develop clinical care guidelines tailored for this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better outcomes for patients with critical limb ischemia and end-stage renal disease.
How similar studies have gone: While there is limited existing literature on this specific patient population, similar studies have shown the importance of real-world evidence in improving treatment outcomes for complex conditions.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Shah, Samir Kaushik — University of Florida
- Study coordinator: Shah, Samir Kaushik
Related research
Other NIH-funded projects on the same topics.
-
How life circumstances affect brain aging in people with end-stage kidney disease
This project looks at how neighborhood, income, education, and personal resilience relate to earlier memory and thinking problems in adults with end-stage kidney disease.
-
How life circumstances affect memory and thinking in people with end-stage kidney disease
Researchers will look at how social and economic factors relate to memory and thinking problems across adults with end-stage kidney disease.
-
How long the shingles (zoster) vaccine protects people with kidney failure, before and after transplant
This project checks how long the shingles vaccine protects adults with end-stage kidney disease who are waiting for or have received a kidney transplant.
-
Activating a cell protein to prevent early dialysis fistula failure
This research tests a drug-like activator of the Mac-1 protein to reduce inflammation and help new dialysis fistulas work better for people with end-stage kidney disease.
-
Ultrasound-activated implants to restore blood flow in severe leg ischemia
This project develops ultrasound-triggered implants that release blood-vessel–growing proteins to help people with critical limb ischemia regain circulation.
-
Pain care for veterans with end-stage kidney disease
This project looks at how changes in VA opioid policies have affected pain control and safety for veterans with end-stage kidney disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.